Gut fibrosis with altered colonic contractility in a mouse model of scleroderma

Rheumatology (United Kingdom)

Volumn 51, Issue 11, 2012, Pages 1989-1998

  Thoua, Nora M ^a   Derrett smith, Emma C ^b   Khan, Korsa ^b   Dooley, Audrey ^b   Shi wen, Xu ^b   Denton, Christopher P ^b  

^a HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Dysmotility; Fibrosis; Gastrointestinal tract; Mouse model; Systemic sclerosis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; KI 67 ANTIGEN; POTASSIUM CHLORIDE; PROTEIN S 100; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IMMUNOCHEMISTRY; INTESTINAL FIBROSIS; INTESTINE CONTRACTION; MALE; MOUSE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCLERODERMA; UPREGULATION; WILD TYPE;

ANIMALS; CARBACHOL; CHOLINERGIC AGONISTS; COLON; COLONIC DISEASES; FEMALE; FIBROBLASTS; FIBROSIS; GASTROINTESTINAL MOTILITY; MALE; MICE; MICE, TRANSGENIC; MUSCLE CONTRACTION; MUSCLE, SMOOTH; SCLERODERMA, SYSTEMIC;

EID: 84867830643     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes191     Document Type: Article

References (29)

1. Sjogren RW. Gastrointestinal motility disorders in scleroderma. Arthritis Rheum 1994; 37: 1265-82.
2. Sallam H, McNearney TA, Chen JD. Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma). Aliment Pharmacol Ther 2006; 23: 691-712.
3. Thoua NM, Bunce C, Brough G, Forbes A, Emmanuel AV, Denton CP. Assessment of gastrointestinal symptoms in patients with systemic sclerosis in a UK tertiary referral centre. Rheumatology 2010; 49: 1770-5.
4. Marie I, Ducrotte P, Denis P, Hellot MF, Levesque H. Outcome of small-bowel motor impairment in systemic sclerosis-a prospective manometric 5-yr follow-up. Rheumatology 2007; 46: 150-3.
5. Greydanus MP, Camilleri M. Abnormal postcibal antral and small bowel motility due to neuropathy or myopathy in systemic sclerosis. Gastroenterology 1989; 96: 110-5.
6. Iovino P, Valentini G, Ciacci C et al. Proximal stomach function in systemic sclerosis: relationship with autonomic nerve function. Dig Dis Sci 2001; 46: 723-30.
7. Manetti M, Neumann E, Milia AF et al. Severe fibrosis and increased expression of fibrogenic cytokines in the gastric wall of systemic sclerosis patients. Arthritis Rheum 2007; 56: 3442-7.
8. Beyer C, Schett G, Distler O, Distler JH. Animal models of systemic sclerosis: prospects and limitations. Arthritis Rheum 2010; 62: 2831-44.
9. Derrett-Smith EC, Denton CP, Sonnylal S. Animal models of scleroderma: lessons from transgenic and knockout mice. Curr Opin Rheumatol 2009; 21: 630-5.
10. Denton CP, Zheng B, Evans LA et al. Fibroblast-specific expression of a kinase-deficient type II transforming growth factor beta (TGFbeta) receptor leads to paradoxical activation of TGFbeta signaling pathways with fibrosis in transgenic mice. J Biol Chem 2003; 278: 25109-19.
11. Denton CP, Lindahl GE, Khan K et al. Activation of key profibrotic mechanisms in transgenic fibroblasts expressing kinase-deficient type II transforming growth factor-{beta} receptor (T{beta}RII{delta}k). J Biol Chem 2005; 280: 16053-65.
12. Hoyles RK, Khan K, Shiwen X et al. Fibroblast-specific perturbation of transforming growth factor beta signaling provides insight into potential pathogenic mechanisms of scleroderma-associated lung fibrosis: exaggerated response to alveolar epithelial injury in a novel mouse model. Arthritis Rheum 2008; 58: 1175-88.
13. De Man JG, Boeckx S, Anguille S et al. Functional study on TRPV1-mediated signalling in the mouse small intestine: involvement of tachykinin receptors. Neurogastroenterol Motil 2008; 20: 546-56.
14. De Man JG, De Winter BY, Herman AG, Pelckmans PA. Study on the cyclic GMP-dependency of relaxations to endogenous and exogenous nitric oxide in the mouse gastrointestinal tract. Br J Pharmacol 2007; 150: 88-96.
15. Tuladhar BR, Womack MD, Naylor RJ. Pharmacological characterization of the 5-HT receptor-mediated contraction in the mouse isolated ileum. Br J Pharmacol 2000; 131: 1716-22.
16. Derrett-Smith EC, Dooley A, Khan K, Shi-Wen X, Abraham D, Denton CP. Systemic vasculopathy with altered vasoreactivity in a transgenic mouse model of scleroderma. Arthritis Res Ther 2010; 12: R69.
17. Vandesompele J, De Preter K, Pattyn F et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3: RESEARCH0034.1-.11.
18. Fjellbirkeland L, Cambier S, Broaddus VC et al. Integrin alphavbeta8-mediated activation of transforming growth factor-beta inhibits human airway epithelial proliferation in intact bronchial tissue. Am J Pathol 2003; 163: 533-42.
19. Gershwin ME, Abplanalp H, Castles JJ et al. Characterization of a spontaneous disease of white leghorn chickens resembling progressive systemic sclerosis (scleroderma). J Exp Med 1981; 153: 1640-59.
20. Nguyen VA, Sgonc R, Dietrich H, Wick G. Endothelial injury in internal organs of University of California at Davis line 200 (UCD 200) chickens, an animal model for systemic sclerosis (scleroderma). J Autoimmun 2000; 14: 143-9.
21. Fichtner-Feigl S, Fuss IJ, Young CA et al. Induction of IL-13 triggers TGF-beta1-dependent tissue fibrosis in chronic 2,4,6-trinitrobenzene sulfonic acid colitis. J Immunol 2007; 178: 5859-70.
22. Engel AF, Kamm MA, Talbot IC. Progressive systemic sclerosis of the internal anal sphincter leading to passive faecal incontinence. Gut 1994; 35: 857-9.
23. Ebert EC. Esophageal disease in scleroderma. J Clin Gastroenterol 2006; 40: 769-75.
24. Marie I, Levesque H, Ducrotte P et al. Manometry of the upper intestinal tract in patients with systemic sclerosis: a prospective study. Arthritis Rheum 1998; 41: 1874-83.
25. Malandrini A, Selvi E, Villanova M et al. Autonomic nervous system and smooth muscle cell involvement in systemic sclerosis: ultrastructural study of 3 cases. J Rheumatol 2000; 27: 1203-6.
26. Manetti M, Milia AF, Benelli G, Messerini L, Matucci-Cerinic M, Ibba-Manneschi L. The gastric wall in systemic sclerosis patients: a morphological study. Ital J Anat Embryol 2010; 115: 115-21.
27. Akesson A, Ekman R. Gastrointestinal regulatory peptides in systemic sclerosis. Arthritis Rheum 1993; 36: 698-703.
28. Howe S, Eaker EY, Sallustio JE, Peebles C, Tan EM, Williams RC Jr. Antimyenteric neuronal antibodies in scleroderma. J Clin Invest 1994; 94: 761-70.
29. Goldblatt F, Gordon TP, Waterman SA. Antibody-mediated gastrointestinal dysmotility in scleroderma. Gastroenterology 2002; 123: 1144-50.